Log in

Esperion Therapeutics Earnings Date, Estimates & History

+1.36 (+3.59 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $39.20
50-Day Range
MA: $35.94
52-Week Range
Now: $39.20
Volume996,601 shs
Average Volume737,227 shs
Market Capitalization$1.09 billion
P/E RatioN/A
Dividend YieldN/A


Esperion Therapeutics (NASDAQ:ESPR) Earnings Information

Esperion Therapeutics last posted its quarterly earnings data on August 10th, 2020. The biopharmaceutical company reported $4.32 earnings per share for the quarter, topping the consensus estimate of $2.13 by $2.19. The business earned $212.24 million during the quarter, compared to analysts' expectations of $147.97 million. Its quarterly revenue was up 21557.1% compared to the same quarter last year. Esperion Therapeutics has generated ($3.59) earnings per share over the last year. Esperion Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 4th, 2020 based off prior year's report dates.

Esperion Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Esperion Therapeutics (NASDAQ:ESPR) Earnings Estimates

2020 EPS Consensus Estimate: $0.18
2021 EPS Consensus Estimate: ($8.72)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($2.71)($2.71)($2.71)
Q2 20201$3.94$3.94$3.94
Q3 20201($3.59)($3.59)($3.59)
Q4 20201$2.54$2.54$2.54
Q1 20211($2.79)($2.79)($2.79)
Q2 20211($2.41)($2.41)($2.41)
Q3 20211($2.02)($2.02)($2.02)
Q4 20211($1.50)($1.50)($1.50)

Esperion Therapeutics (NASDAQ ESPR) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/10/20206/30/2020$2.13$4.32$4.32$147.97 million$212.24 millionTranscript
5/6/20203/31/2020($3.14)($2.84)($2.84)$0.39 million$1.80 millionTranscript
2/27/2020Q4 2019($2.67)($2.26)($2.26)$0.99 million$0.98 millionN/A
11/6/2019Q3 2019($1.95)($2.37)($2.52)$0.99 million$0.98 millionN/A
8/8/2019Q2 2019($1.86)($2.01)($2.01)$1.05 million$0.98 millionN/A
5/8/20193/31/2019$0.64$3.07$3.07$69.35 million$145.42 millionN/A
2/28/2019Q4 2018($1.30)($2.24)($2.24)N/A
11/1/2018Q3 2018($1.58)($1.86)($1.86)N/A
8/2/2018Q2 2018($1.6950)($1.71)($1.71)N/A
5/2/2018Q1 2018($1.56)($1.73)($1.73)N/A
2/20/2018Q4 2017($1.80)($1.44)($1.44)N/A
11/7/2017Q3 2017($1.79)($1.86)($1.86)N/A
8/8/2017Q2 2017($1.67)($1.92)($1.92)Listen
5/4/2017Q1 2017($1.48)($1.80)($1.80)N/A
3/5/2015Q4 2014($0.54)($0.49)($0.49)N/A
11/10/2014Q3 2014($0.68)($0.64)($0.64)N/A
5/12/2014Q1 2014($0.62)($0.51)($0.51)N/A
3/5/2014Q4 2013($0.46)($0.63)($0.63)N/A
11/6/2013Q3 2013($0.41)($0.34)($0.34)N/A
8/12/2013Q2 2013($12.53)($5.24)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.